ATX-II TFA is a selective sodium channel modulator toxin that enhances late sodium current, prevents full sodium channel inactivation, and generates persistent current fractions. It has a pro-arrhythmic effect, slowing intrinsic heart rate and prolonging QT interval. This compound is suitable for research on atrial fibrillation, long QT syndrome, and long QT3 syndrome.